Article
Evolution of Allogeneic Stem Cell Transplantation: Main Focus on AML
10 Apr 2025
Abstract excerpt
In recent years, treatments in the field of hematologic malignancies have undergone significant evolution; allogeneic hematopoietic stem cell transplantation (allo-HSCT) has shifted from an "ultimate" therapy to becoming a component of a comprehensive therapeutic strategy for acute myeloid leukemia (AML). Advances in risk stratification (including molecular profiling and measurable residual disease assessment),...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
